Intravenous Infusions Plc (GHSE:IIL)

Intravenous Infusions Revenue

Intravenous Infusions had revenue of 7.07M GHS in the half year ending June 30, 2025, a decrease of -47.87%. This brings the company's revenue in the last twelve months to 19.40M, down -36.32% year-over-year. In the year 2024, Intravenous Infusions had annual revenue of 24.94M, down -20.62%.

• Revenue (ttm): 19.40M
• Revenue Growth: -36.32%
• P/S Ratio: 0.71
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 13.72M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	24.94M	-6.48M	-20.62%
Dec 31, 2023	31.42M	11.06M	54.34%
Dec 31, 2022	20.36M	-2.32M	-10.21%
Dec 31, 2021	22.67M	2.00M	9.69%
Dec 31, 2020	20.67M	-2.42M	-10.47%